Download PDFPDF
Novel treatment (new drug/intervention; established drug/procedure in new situation)
The use of a portable digital thoracic suction Thopaz drainage system for the management of a persistent spontaneous secondary pneumothorax in a patient with underlying interstitial lung disease
Compose Response

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.
Author Information
First or given name, e.g. 'Peter'.
Your last, or family, name, e.g. 'MacMoody'.
Your email address, e.g.
Your role and/or occupation, e.g. 'Orthopedic Surgeon'.
Your organization or institution (if applicable), e.g. 'Royal Free Hospital'.
Statement of Competing Interests


  • Responses are moderated before posting and publication is at the absolute discretion of BMJ, however they are not peer-reviewed
  • Once published, you will not have the right to remove or edit your response. Removal or editing of responses is at BMJ's absolute discretion
  • If patients could recognise themselves, or anyone else could recognise a patient from your description, please obtain the patient's written consent to publication and send them to the editorial office before submitting your response [Patient consent forms]
  • By submitting this response you are agreeing to our full [Response terms and requirements]

Vertical Tabs

Other responses

  • Published on:
    The digital thoracic drainage could be a new tool for very selected ambulatory patients.

    I have read with interest the paper by Jenkins et al on discharging a patient to home with a Thopaz drain thus avoiding a surgical procedure. I agree with the author on the benefits of digital thoracic drainage devices. The author does reference previous work by Cerfolio RJ and Brunelli A, in our experience (Mier JM, Molins L, Fibla JJ Cir Esp. 2010(6):385-9) in a prospective and comparative study we demonstrate the benefi...

    Show More
    Conflict of Interest:
    None declared.